The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Donald Trump says he spoke with his friend after he used a story about him buying the 'fat drug shot' overseas at a ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.

The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.

Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

A woman who lost 55 pounds on Ozempic opens up about the most difficult side effect she faced—and shares simple tips that ...